Ribosomal protein L26 pseudogene 29 (RPL26P29)

Ribosomal protein L26 pseudogene 29 (RPL26P29) is a processed pseudogene in the human genome, annotated as a non-coding genomic element with sequence similarity to the functional RPL26 gene. Unlike protein-coding genes, pseudogenes such as RPL26P29 do not code for functional proteins and generally lack biological function or roles in disease, drug targeting, or biomarker development[2][3][7][8]. There is no evidence that RPL26P29 acts as a therapeutic target, nor is it associated with regulatory, receptor, enzyme, or transporter activity. Its annotation as a pseudogene means it is essentially a non-functional relic of gene duplication or retrotransposition[3][8]. RPL26P29 is frequently listed in genomic databases as a pseudogene, not a protein-coding gene nor a functional molecular target[2][3][8]. This means it is *not* a receptor, enzyme, transporter, transcription factor, or valid therapeutic target. Its relevance is limited to genomics and evolutionary biology, primarily as evidence of gene duplication history. There are no known drugs or safety concerns associated with RPL26P29, nor does it have described roles as a biomarker or in disease. If you intended the functional ribosomal protein or ribosomal protein L26 (RPL26), that is a different gene with biological and disease relevance[5].

Other names

RPL26_14_1054RPL26P29